Knowledge Center
Patent / Jan 01, 1973
16.beta.-Methyl-17-hydroxypregna-1,4,9(11)-triene-3,20-dione
Source:
GB 1397267
The title compd. (I), useful as intermediate for the manuf. of betametasone, was prepd. Partial ketalization of the trioxo compd. (II), KBH4 redn. of the resulting oxo compd. (III), and subsequent dehydration by MeSO2Cl contg. SO3 gave the epoxypregnene (IV). Grignard reaction of IV with MeMgBr gave the methylhydroxy deriv. (V) and subsequent deketalization the dione (VI), which on 2-step bromination-dehydrobromination or 1-step dehydrogenation by dichlorodicyanobenzoquinone led to I.
Also in the Knowledge Center
/ Sep 25, 2021
Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution
Read more
Scientific Article
Scientific Article
/ Apr 09, 2021
Analytical Method Lifecycle Management in Pharmaceutical Industry: a Review
Read more
Scientific Article